Education
About Us
Working with TipRanks
Follow Us
Olympus (OLYMY)
OTHER OTC:OLYMY
OLYMY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.11 - $19.79
Previous CloseN/A
Volume14.55K
Average Volume (3M)11.23K
Market Cap
$13.70B
Enterprise Value$15.06B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)18.0
Beta0.59
Next Earnings
Nov 07, 2025EPS Estimate
0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding1,139,116,300
10 Day Avg. Volume7,139
30 Day Avg. Volume11,233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Olympus News
OLYMY FAQ
What was Olympus’s price range in the past 12 months?
Olympus lowest stock price was $11.11 and its highest was $19.79 in the past 12 months.
What is Olympus’s market cap?
Olympus’s market cap is $13.70B.
When is Olympus’s upcoming earnings report date?
Olympus’s upcoming earnings report date is Nov 07, 2025 which is in 91 days.
How were Olympus’s earnings last quarter?
Olympus released its earnings results on Aug 06, 2025. The company reported $0.411 earnings per share for the quarter, beating the consensus estimate of $0.117 by $0.294.
Is Olympus overvalued?
According to Wall Street analysts Olympus’s price is currently Overvalued.
Does Olympus pay dividends?
Olympus does not currently pay dividends.
What is Olympus’s EPS estimate?
Olympus’s EPS estimate is 0.14.
How many shares outstanding does Olympus have?
Olympus has 1,139,116,300 shares outstanding.
What happened to Olympus’s price movement after its last earnings report?
Olympus reported an EPS of $0.411 in its last earnings report, beating expectations of $0.117. Following the earnings report the stock price went up 0.903%.
Which hedge fund is a major shareholder of Olympus?
Currently, no hedge funds are holding shares in OLYMY
Olympus Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.67%
12-Months-Change
Fundamentals
Return on Equity
15.47%
Trailing 12-Months
Asset Growth
-5.48%
Trailing 12-Months
Company Description
Olympus
Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
OLYMY Company Deck
OLYMY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong sales growth in North America and record revenue achievement, alongside a dividend increase and new product launches. However, challenges in China, potential impacts from U.S. tariffs, and increased R&D expenses present notable concerns. The appointment of a new CEO is seen as a positive step towards addressing these challenges.View all OLYMY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---